120 related articles for article (PubMed ID: 37079942)
1. Skeletal muscle atrophy and short-term mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis: an observational cohort study.
Ito Y; Anan K; Awano N; Kataoka Y; Johkoh T; Fujimoto K; Ichikado K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Yamamoto Y; Inomata M; Izumo T
Respir Investig; 2023 Jul; 61(4):371-378. PubMed ID: 37079942
[TBL] [Abstract][Full Text] [Related]
2. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan.
Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Sugimoto C; Tanaka T; Sumikawa H; Suzuki Y; Fujisawa T; Suda T; Izumo T
Respir Investig; 2020 Mar; 58(2):91-101. PubMed ID: 31882370
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
Tanimura K; Sato S; Fuseya Y; Hasegawa K; Uemasu K; Sato A; Oguma T; Hirai T; Mishima M; Muro S
Ann Am Thorac Soc; 2016 Mar; 13(3):334-41. PubMed ID: 26700501
[TBL] [Abstract][Full Text] [Related]
4. Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients.
Moon SW; Choi JS; Lee SH; Jung KS; Jung JY; Kang YA; Park MS; Kim YS; Chang J; Kim SY
Respir Res; 2019 Feb; 20(1):35. PubMed ID: 30767787
[TBL] [Abstract][Full Text] [Related]
5. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
Suzuki Y; Yoshimura K; Enomoto Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
Sci Rep; 2018 Sep; 8(1):14074. PubMed ID: 30232390
[TBL] [Abstract][Full Text] [Related]
6. Appendicular Skeletal Muscle Mass Correlates with Patient-Reported Outcomes and Physical Performance in Patients with Idiopathic Pulmonary Fibrosis.
Ebihara K; Iwanami Y; Yamasaki K; Takemura A; Sato N; Usui Y; Nakamura Y; Kishi K; Homma S; Ebihara S
Tohoku J Exp Med; 2021 Jan; 253(1):61-68. PubMed ID: 33473063
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of the cross-sectional area of the erector spinae muscle in patients with pleuroparenchymal fibroelastosis.
Kitahara S; Abe M; Kono C; Sakuma N; Ishii D; Kawasaki T; Ikari J; Suzuki T
Sci Rep; 2023 Oct; 13(1):17289. PubMed ID: 37828047
[TBL] [Abstract][Full Text] [Related]
8. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis.
Nakano A; Ohkubo H; Taniguchi H; Kondoh Y; Matsuda T; Yagi M; Furukawa T; Kanemitsu Y; Niimi A
Sci Rep; 2020 Feb; 10(1):2312. PubMed ID: 32047177
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the thickness of erector spinae muscles and mortality in patients with pulmonary tuberculosis.
Shimoda M; Yoshiyama T; Tanaka Y; Morimoto K; Okumura M; Kodama T; Nakajima K; Yoshimori K; Ohta K
Respir Investig; 2023 Jul; 61(4):511-519. PubMed ID: 37267852
[TBL] [Abstract][Full Text] [Related]
10. Accelerated Loss of Antigravity Muscles Is Associated with Mortality in Patients with COPD.
Tanimura K; Sato S; Sato A; Tanabe N; Hasegawa K; Uemasu K; Hamakawa Y; Oguma T; Muro S; Hirai T
Respiration; 2020; 99(4):298-306. PubMed ID: 32235124
[TBL] [Abstract][Full Text] [Related]
11. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
Suzuki Y; Aono Y; Kono M; Hasegawa H; Yokomura K; Naoi H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Nakamura H; Suda T
Respirology; 2021 Feb; 26(2):171-179. PubMed ID: 32969124
[TBL] [Abstract][Full Text] [Related]
12. Low Daily Step Count Associated with Small Erector Spinae Muscle Area and Sarcopenia in Idiopathic Pulmonary Fibrosis.
Ohkubo H; Fujita K; Ito K; Nakano A; Horiuchi M; Mori Y; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Ito Y; Ozawa Y; Murase T; Niimi A
Intern Med; 2024 May; 63(10):1345-1352. PubMed ID: 37839878
[TBL] [Abstract][Full Text] [Related]
13. Acute reduction of erector spinae muscle cross-sectional area is associated with ICU-AW and worse prognosis in patients with mechanical ventilation in the ICU: A prospective observational study.
Yuan G; Zhang J; Mou Z; Luo J; Xie Y
Medicine (Baltimore); 2021 Nov; 100(47):e27806. PubMed ID: 34964749
[TBL] [Abstract][Full Text] [Related]
14. Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis.
Fujikawa T; Kondo S; Saito T; Inoue T; Otake K; Misu S; Sakai H; Ono R; Tomioka H
Respir Med Res; 2022 Nov; 82():100965. PubMed ID: 36283327
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of erector spinae muscles in patients with Mycobacterium avium complex lung disease.
Asakura T; Yamada Y; Suzuki S; Namkoong H; Okamori S; Kusumoto T; Niijima Y; Ozaki A; Hashimoto M; Yagi K; Kamata H; Funatsu Y; Ishii M; Jinzaki M; Betsuyaku T; Hasegawa N
Respir Med; 2018 Dec; 145():66-72. PubMed ID: 30509718
[TBL] [Abstract][Full Text] [Related]
16. Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.
Cao MS; Sheng J; Wang TZ; Qiu XH; Wang DM; Wang Y; Xiao YL; Cai HR
Chin Med J (Engl); 2019 Sep; 132(18):2177-2184. PubMed ID: 31490258
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy.
Araki T; Kitaguchi Y; Suzuki Y; Komatsu M; Sonehara K; Wada Y; Tateishi K; Hanaoka M
Thorac Cancer; 2021 Nov; 12(21):2857-2864. PubMed ID: 34599854
[TBL] [Abstract][Full Text] [Related]
19. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
[No Abstract] [Full Text] [Related]
20. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]